Gene associated with cilostazol side effect, headache

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000431

Enrollment

Registered

2012-05-03

Start date

2011-09-05

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Blood sampling after Cilostazol administration 1. IR Cilostazol, 2 oral doses (100mg x 2 tablets) ->7 days apart, SR Cilostazol single oral dose (200mg x 1 tablet) 2. SR Cilostazol single ora

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal control with cilostazol

Exclusion criteria

Exclusion criteria: Compliance problem

Design outcomes

Primary

Measure	Time frame
Headache	—

Secondary

Measure	Time frame
Drug concentration	—

Countries

Korea, Republic of

Contacts

Public ContactHyung Soon Park

Yonsei University

Outcome results